Stable subcutaneous protein formulations and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10265401
APP PUB NO 20160263223A1
SERIAL NO

15066480

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates generally to stable formulations comprising CTLA4Ig molecules, including lyophilized, and liquid formulations for administration via various routes including, for example, routes such as intravenous (IV) and subcutaneous (SC) for treating immune system diseases and tolerance induction.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BRISTOL-MYERS SQUIBB COMPANYPRINCETON NJ

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Borsadia, Sunita Plainsboro, US 6 84
Dahlheim, Charles E Lawrenceville, US 15 105
Desai, Manisha P Wayne, US 4 1
Gandhi, Rajesh Babulal Plainsboro, US 8 89
Naringrekar, Vijay H Princeton, US 24 197
Nerurkar, Manoj Bellandur, IN 27 300

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Oct 23, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 23, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00